A novel PPARalpha agonist ameliorates insulin resistance in dogs fed a high-fat diet.
about
Cross-species gene expression analysis of species specific differences in the preclinical assessment of pharmaceutical compoundsTargeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic DrugsHepatic glycogen supercompensation activates AMP-activated protein kinase, impairs insulin signaling, and reduces glycogen deposition in the liver.HPLC-DAD Method for the Pharmacokinetic Interaction Study of Atorvastatin with Pioglitazone and Cholestyramine in Wistar Rats.Fenofibrate administration to arthritic rats increases adiponectin and leptin and prevents oxidative muscle wasting.Peroxisome proliferator-activated receptor-alpha activator fenofibrate prevents high-fat diet-induced renal lipotoxicity in spontaneously hypertensive rats.
P2860
A novel PPARalpha agonist ameliorates insulin resistance in dogs fed a high-fat diet.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
A novel PPARalpha agonist ameliorates insulin resistance in dogs fed a high-fat diet.
@en
A novel PPARalpha agonist ameliorates insulin resistance in dogs fed a high-fat diet.
@nl
type
label
A novel PPARalpha agonist ameliorates insulin resistance in dogs fed a high-fat diet.
@en
A novel PPARalpha agonist ameliorates insulin resistance in dogs fed a high-fat diet.
@nl
prefLabel
A novel PPARalpha agonist ameliorates insulin resistance in dogs fed a high-fat diet.
@en
A novel PPARalpha agonist ameliorates insulin resistance in dogs fed a high-fat diet.
@nl
P2093
P2860
P1476
A novel PPARalpha agonist ameliorates insulin resistance in dogs fed a high-fat diet.
@en
P2093
Koji Murakami
Mari Utsumi
Masaki Tsunoda
Michiaki Nagasawa
Naoki Kobayashi
Tomohiro Ide
P2860
P304
P356
10.1152/AJPENDO.00627.2007
P577
2008-01-22T00:00:00Z